BRCA1 gene mutation

From Aaushi
Jump to navigation Jump to search

Introduction

see BRCA1/BRCA2 genotyping

Genetics

Complications

Management

More general terms

Additional terms

References

  1. 1.0 1.1 Kuchenbaecker KB, Hopper JL, Barnes DR et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 2017 Jun 20; 317:2402. <PubMed> PMID: https://pubmed.ncbi.nlm.nih.gov/28632866 <Internet> http://jamanetwork.com/journals/jama/article-abstract/2632503
  2. 2.0 2.1 Regev-Sadeh S, Michaelson-Cohen R, Madorksy-Feldman D, et al Hormone Therapy After Oophorectomy and Breast Cancer Risk in Women With BRCA Pathogenic Variant. JAMA Netw Open. 2026 Apr 1;9(4):e265648. PMID: https://pubmed.ncbi.nlm.nih.gov/41949865 PMCID: PMC13063081 Free PMC article. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2847514
  3. 3.0 3.1 Tung NM, Boughey JC, Pierce LJ, et al Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline. J Clin Oncol. 2020 Jun 20;38(18):2080-2106. PMID: https://pubmed.ncbi.nlm.nih.gov/32243226
  4. 4.0 4.1 O'Reilly C, McGarry JL, Zaborowski AM, Risk-Reducing Bilateral Mastectomy and Mortality in Carriers of BRCA1 and BRCA2 Variants: A Systematic Review and Meta-Analysis. JAMA Surg. 2026 Mar 1;161(3):260-267. PMID: https://pubmed.ncbi.nlm.nih.gov/41499127 PMCID: PMC12780977 (available on 2027-01-07) https://jamanetwork.com/journals/jamasurgery/fullarticle/2843262
  5. 5.0 5.1 Apostol AI, Kotsopoulos J, Gronwald J, et al Ovarian cancer after breast cancer in women with a BRCA1 or BRCA2 pathogenic variant. Gynecol Oncol. 2025 Oct;201:44-52. doi:http://dx.doi.org/ 10.1016/j.ygyno.2025.07.030. Epub 2025 Aug 9. PMID: https://pubmed.ncbi.nlm.nih.gov/40784323